<DOC>
	<DOCNO>NCT01144611</DOCNO>
	<brief_summary>This multi-centre prospective , randomised , double-blind , placebo-controlled study design evaluate efficacy safety bovine intestinal alkaline phosphatase ( bIAP ) reduce pro-inflammatory post-surgical response thereby preserve organ function patient undergo invasive cardiac surgery : combine aortic valve replacement coronary artery bypass grafting .</brief_summary>
	<brief_title>Efficacy Safety Bovine Intestinal Alkaline Phosphatase ( bIAP ) During Heart Surgery</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<criteria>Male nonpregnant , nonlactating female patient race age &gt; 18 year . Patients schedule combined aortic valve replacement CABG surgery . Patients give write informed consent prior participation trial undertake comply protocol . Patients unwilling unable fully evaluate followup . Patients base AP level &gt; 125 IU/L , level &lt; 30 IU/L ( ammediol , DEA ( diethanolamine ) unit ) Patients show preoperative infection suspect endocarditis systemic infection . Patients refuse accept medicallyindicated blood product . Patients evidence significant hepatic disease , include history clinical sign laboratory value total bilirubin &gt; 34.2 Âµmol/L ( &gt; 2.0 mg/dL ) , ALT ( &gt; 120 ) AST ( &gt; 135 ) correspond &gt; 3X upper limit normal . Patients receive investigational drug 30 day prior study drug administration , currently participate study administration investigational drug within one month anticipate . Patients require preoperative ventilatory support . Patients renal insufficiency ( history creatinine &gt; 177mol/L &gt; 2.0 mg/dL ) chronic renal failure require dialysis . Patients plan receive leukocytedepletion filtration part bypass circuitry . Patients severe neurological deficit . Patients recent history drug alcohol abuse . Patients diagnosis idiopathic thrombocytopenia . Patients history cancer receive chemotherapy radiation therapy within past 3 month . Patients receive adjuvant hormonal therapy exclude . Patients schedule receive `` stress dos '' glucocorticoid ( i.e. , dose &gt; 2 mg/kg/day methylprednisolone equivalent ) prior , follow surgery . Patients vegetarians veganists patient may expect tolerant bovine protein . Patients , opinion investigator , unsuitable study . A welldocumented screen log present clinic .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>valve replacement</keyword>
	<keyword>CABG</keyword>
	<keyword>SIRTS</keyword>
	<keyword>Combined aortic valve replacement CABG surgery</keyword>
</DOC>